AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022
Feb 24, 2022
30339_dirs_2022-02-24_b9926d29-a46b-466b-a2ab-f8b9a191529d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-02-22
Reporting Person: Abraham Silji (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-22 | Common Stock | A | 2498.00 | $369.13 | Acquired | 8575.2997 | Direct |
Footnotes
F1: 2019 PSUs (PP18) award vesting net of taxes withheld
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27